This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Geynisman DM , Maranchie JK , Ball MW , Bratslavsky G , Singer EA
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer
Urol Oncol. 2021 Sep;39(9) :548-560
PMID: 34092483 URL: https://www.ncbi.nlm.nih.gov/pubmed/34092483
AbstractThe diagnosis, evaluation and management of patients with renal cell carcinoma has transformed in the 21st century. Utilizing biological discoveries and technological advances, the field has moved from blunt surgical and largely ineffective medical treatments, to nuanced and fine-tuned approaches based on biology, extent of disease and patient preferences. In this review we will summarize the last 25 years of progress in kidney cancer.
Notes1873-2496 Geynisman, Daniel M Maranchie, Jodi K Ball, Mark W Bratslavsky, Gennady Singer, Eric A Journal Article Review United States Urol Oncol. 2021 Jun 4:S1078-1439(21)00194-0. doi: 10.1016/j.urolonc.2021.04.038.